• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

脑内海绵状血管畸形通过突变内皮细胞的克隆扩张发展。

Cerebral Cavernous Malformations Develop Through Clonal Expansion of Mutant Endothelial Cells.

机构信息

From the Molecular Genetics and Microbiology Department (M.R.D., D.A.S., D.A.M.), Duke University School of Medicine, Durham, NC.

Medical Scientist Training Program (M.R.D.), Duke University School of Medicine, Durham, NC.

出版信息

Circ Res. 2018 Oct 26;123(10):1143-1151. doi: 10.1161/CIRCRESAHA.118.313970.

DOI:10.1161/CIRCRESAHA.118.313970
PMID:30359189
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6205520/
Abstract

RATIONALE

Vascular malformations arise in vessels throughout the entire body. Causative genetic mutations have been identified for many of these diseases; however, little is known about the mutant cell lineage within these malformations.

OBJECTIVE

We utilize an inducible mouse model of cerebral cavernous malformations (CCMs) coupled with a multicolor fluorescent reporter to visualize the contribution of mutant endothelial cells (ECs) to the malformation.

METHODS AND RESULTS

We combined a Ccm3 mouse model with the confetti fluorescent reporter to simultaneously delete Ccm3 and label the mutant EC with 1 of 4 possible colors. We acquired Z-series confocal images from serial brain sections and created 3-dimensional reconstructions of entire CCMs to visualize mutant ECs during CCM development. We observed a pronounced pattern of CCMs lined with mutant ECs labeled with a single confetti color (n=42). The close 3-dimensional distribution, as determined by the nearest neighbor analysis, of the clonally dominant ECs within the CCM was statistically different than the background confetti labeling of ECs in non-CCM control brain slices as well as a computer simulation ( P<0.001). Many of the small (<100 μm diameter) CCMs consisted, almost exclusively, of the clonally dominant mutant ECs labeled with the same confetti color, whereas the large (>100 μm diameter) CCMs contained both the clonally dominant mutant cells and wild-type ECs. We propose of model of CCM development in which an EC acquires a second somatic mutation, undergoes clonal expansion to initiate CCM formation, and then incorporates neighboring wild-type ECs to increase the size of the malformation.

CONCLUSIONS

This is the first study to visualize, with single-cell resolution, the clonal expansion of mutant ECs within CCMs. The incorporation of wild-type ECs into the growing malformation presents another series of cellular events whose elucidation would enhance our understanding of CCMs and may provide novel therapeutic opportunities.

摘要

背景

血管畸形发生于全身各处的血管。许多此类疾病的致病基因突变已被鉴定;然而,对于这些畸形中的突变细胞谱系知之甚少。

目的

我们利用诱导型脑海绵状血管畸形(CCM)小鼠模型和多色荧光报告基因来可视化突变内皮细胞(EC)对畸形的贡献。

方法和结果

我们将 Ccm3 小鼠模型与 confetti 荧光报告基因相结合,同时删除 Ccm3 并将突变 EC 用 4 种可能颜色中的 1 种标记。我们从连续脑切片中获取 Z 系列共聚焦图像,并创建整个 CCM 的 3 维重建,以在 CCM 发育过程中可视化突变 EC。我们观察到具有突变 EC 用单一 confetti 颜色标记的 CCM 明显排列模式(n=42)。通过最近邻分析确定的 CCM 内克隆优势 EC 的紧密 3 维分布与非 CCM 对照脑切片中的 EC 的背景 confetti 标记以及计算机模拟有显著差异(P<0.001)。许多较小(<100 μm 直径)的 CCM 几乎完全由用相同 confetti 颜色标记的克隆优势突变 EC 组成,而较大(>100 μm 直径)的 CCM 则包含克隆优势突变细胞和野生型 EC。我们提出了 CCM 发展的模型,其中 EC 获得第二次体细胞突变,经历克隆扩张以启动 CCM 形成,然后整合邻近的野生型 EC 以增加畸形的大小。

结论

这是第一项以单细胞分辨率可视化 CCM 内突变 EC 克隆扩张的研究。野生型 EC 整合到不断增长的畸形中呈现出一系列新的细胞事件,阐明这些事件将增强我们对 CCM 的理解,并可能提供新的治疗机会。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1a19/6205520/85717cd06266/nihms-1507073-f0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1a19/6205520/275074caae74/nihms-1507073-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1a19/6205520/2565f928c9b3/nihms-1507073-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1a19/6205520/f681b1b9ba31/nihms-1507073-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1a19/6205520/85717cd06266/nihms-1507073-f0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1a19/6205520/275074caae74/nihms-1507073-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1a19/6205520/2565f928c9b3/nihms-1507073-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1a19/6205520/f681b1b9ba31/nihms-1507073-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1a19/6205520/85717cd06266/nihms-1507073-f0004.jpg

相似文献

1
Cerebral Cavernous Malformations Develop Through Clonal Expansion of Mutant Endothelial Cells.脑内海绵状血管畸形通过突变内皮细胞的克隆扩张发展。
Circ Res. 2018 Oct 26;123(10):1143-1151. doi: 10.1161/CIRCRESAHA.118.313970.
2
Differential angiogenesis function of CCM2 and CCM3 in cerebral cavernous malformations.CCM2 和 CCM3 在脑动静脉畸形中的差异血管生成功能。
Neurosurg Focus. 2010 Sep;29(3):E1. doi: 10.3171/2010.5.FOCUS1090.
3
Endothelial Cell-Pericyte Interactions in the Pathogenesis of Cerebral Cavernous Malformations (CCMs).内皮细胞-周细胞相互作用在脑静脉畸形(CCMs)发病机制中的作用。
Cold Spring Harb Perspect Med. 2023 Mar 1;13(3):a041188. doi: 10.1101/cshperspect.a041188.
4
In vitro characterization of the angiogenic phenotype and genotype of the endothelia derived from sporadic cerebral cavernous malformations.体外鉴定散发性脑动静脉畸形血管内皮的血管生成表型和基因型。
Neurosurgery. 2011 Sep;69(3):722-31; discussion 731-2. doi: 10.1227/NEU.0b013e318219569f.
5
mTORC1 Signaling in Brain Endothelial Progenitors Contributes to CCM Pathogenesis.mTORC1 信号在脑内皮祖细胞中的作用促进 CCM 发病机制。
Circ Res. 2024 Aug 2;135(4):e94-e113. doi: 10.1161/CIRCRESAHA.123.324015. Epub 2024 Jul 3.
6
Mural Cell-Specific Deletion of Cerebral Cavernous Malformation 3 in the Brain Induces Cerebral Cavernous Malformations.脑内血管性腔隙畸形 3 的壁细胞特异性缺失可诱导脑内血管性腔隙畸形。
Arterioscler Thromb Vasc Biol. 2020 Sep;40(9):2171-2186. doi: 10.1161/ATVBAHA.120.314586. Epub 2020 Jul 9.
7
Endothelial cell clonal expansion in the development of cerebral cavernous malformations.脑动静脉畸形发生中内皮细胞的克隆性扩张。
Nat Commun. 2019 Jun 24;10(1):2761. doi: 10.1038/s41467-019-10707-x.
8
CDC42 Deletion Elicits Cerebral Vascular Malformations via Increased MEKK3-Dependent KLF4 Expression.CDC42 缺失通过增加 MEKK3 依赖性 KLF4 表达引发脑血管畸形。
Circ Res. 2019 Apr 12;124(8):1240-1252. doi: 10.1161/CIRCRESAHA.118.314300.
9
Caveolae-mediated Tie2 signaling contributes to CCM pathogenesis in a brain endothelial cell-specific Pdcd10-deficient mouse model.小窝介导的 Tie2 信号通路促进了脑内皮细胞特异性 Pdcd10 缺失小鼠模型中 CCM 的发病机制。
Nat Commun. 2021 Jan 25;12(1):504. doi: 10.1038/s41467-020-20774-0.
10
CCM3 and cerebral cavernous malformation disease.CCM3 与脑静脉血管畸形病。
Stroke Vasc Neurol. 2019 Mar 2;4(2):67-70. doi: 10.1136/svn-2018-000195. eCollection 2019 Jul.

引用本文的文献

1
Semaphorin 3A and 3F overexpression in TIE2 hyperactive endothelial cells contribute to the pathological lumen expansion in venous malformation.在TIE2过度活跃的内皮细胞中,信号素3A和3F的过表达促成了静脉畸形中的病理性管腔扩张。
bioRxiv. 2025 Jul 24:2025.07.18.665640. doi: 10.1101/2025.07.18.665640.
2
The Role of Somatic Mutation in Hereditary Hemorrhagic Telangiectasia Pathogenesis.体细胞突变在遗传性出血性毛细血管扩张症发病机制中的作用。
J Clin Med. 2025 Jun 24;14(13):4479. doi: 10.3390/jcm14134479.
3
Single-cell transcriptome profiling reveals dynamic cell populations and immune infiltration in cerebral cavernous malformation.

本文引用的文献

1
Vascular Anomalies: From a Clinicohistologic to a Genetic Framework.血管异常:从临床组织学到遗传框架。
Plast Reconstr Surg. 2018 May;141(5):709e-717e. doi: 10.1097/PRS.0000000000004294.
2
Etiology and Genetics of Congenital Vascular Lesions.先天性血管病变的病因学与遗传学
Otolaryngol Clin North Am. 2018 Feb;51(1):41-53. doi: 10.1016/j.otc.2017.09.006.
3
Thrombospondin1 (TSP1) replacement prevents cerebral cavernous malformations.血小板反应蛋白1(TSP1)替代可预防脑海绵状血管畸形。
单细胞转录组分析揭示了脑海绵状血管畸形中的动态细胞群和免疫浸润。
Front Immunol. 2025 May 30;16:1592343. doi: 10.3389/fimmu.2025.1592343. eCollection 2025.
4
High-throughput differentiation of human blood vessel organoids reveals overlapping and distinct functions of the cerebral cavernous malformation proteins.人血管类器官的高通量分化揭示了脑海绵状血管畸形蛋白的重叠和独特功能。
Angiogenesis. 2025 Jun 6;28(3):32. doi: 10.1007/s10456-025-09985-5.
5
Focused ultrasound-microbubble treatment arrests the growth and formation of cerebral cavernous malformations.聚焦超声-微泡治疗可抑制脑海绵状血管畸形的生长和形成。
Nat Biomed Eng. 2025 May 13. doi: 10.1038/s41551-025-01390-z.
6
Pharmacological blocking of neutrophil extracellular traps attenuates immunothrombosis and neuroinflammation in cerebral cavernous malformation.中性粒细胞胞外诱捕网的药理学阻断可减轻海绵状血管瘤中的免疫血栓形成和神经炎症。
Nat Cardiovasc Res. 2024 Dec;3(12):1549-1567. doi: 10.1038/s44161-024-00577-y. Epub 2024 Dec 4.
7
Force-mediated recruitment and reprogramming of healthy endothelial cells drive vascular lesion growth.力介导的健康内皮细胞募集和重编程驱动血管病变生长。
Nat Commun. 2024 Oct 6;15(1):8660. doi: 10.1038/s41467-024-52866-6.
8
KRIT1 in vascular biology and beyond.KRIT1 在血管生物学及其他领域的作用。
Biosci Rep. 2024 Jul 31;44(7). doi: 10.1042/BSR20231675.
9
mTORC1 Signaling in Brain Endothelial Progenitors Contributes to CCM Pathogenesis.mTORC1 信号在脑内皮祖细胞中的作用促进 CCM 发病机制。
Circ Res. 2024 Aug 2;135(4):e94-e113. doi: 10.1161/CIRCRESAHA.123.324015. Epub 2024 Jul 3.
10
Bringing CCM into a dish: cell culture models for cerebral cavernous malformations.将大脑海绵状血管畸形研究引入培养皿:大脑海绵状血管畸形的细胞培养模型
Med Genet. 2021 Dec 3;33(3):251-259. doi: 10.1515/medgen-2021-2091. eCollection 2021 Sep.
J Exp Med. 2017 Nov 6;214(11):3331-3346. doi: 10.1084/jem.20171178. Epub 2017 Sep 28.
4
Combined HMG-COA reductase and prenylation inhibition in treatment of CCM.联合 HMG-COA 还原酶和异戊烯基化抑制治疗 CCM。
Proc Natl Acad Sci U S A. 2017 May 23;114(21):5503-5508. doi: 10.1073/pnas.1702942114. Epub 2017 May 12.
5
Endothelial TLR4 and the microbiome drive cerebral cavernous malformations.内皮细胞Toll样受体4(TLR4)与微生物群引发脑海绵状血管瘤。
Nature. 2017 May 18;545(7654):305-310. doi: 10.1038/nature22075. Epub 2017 May 10.
6
Endothelial exocytosis of angiopoietin-2 resulting from CCM3 deficiency contributes to cerebral cavernous malformation.CCM3缺乏导致的血管生成素-2内皮细胞胞吐作用促成脑海绵状血管畸形。
Nat Med. 2016 Sep;22(9):1033-1042. doi: 10.1038/nm.4169. Epub 2016 Aug 22.
7
Cerebral cavernous malformations arise from endothelial gain of MEKK3-KLF2/4 signalling.脑海绵状血管畸形源于MEKK3-KLF2/4信号通路的内皮细胞功能获得。
Nature. 2016 Apr 7;532(7597):122-6. doi: 10.1038/nature17178. Epub 2016 Mar 30.
8
KLF4 is a key determinant in the development and progression of cerebral cavernous malformations.KLF4是脑海绵状血管畸形发生发展的关键决定因素。
EMBO Mol Med. 2016 Jan 1;8(1):6-24. doi: 10.15252/emmm.201505433.
9
Sulindac metabolites decrease cerebrovascular malformations in CCM3-knockout mice.舒林酸代谢产物可减少CCM3基因敲除小鼠的脑血管畸形。
Proc Natl Acad Sci U S A. 2015 Jul 7;112(27):8421-6. doi: 10.1073/pnas.1501352112. Epub 2015 Jun 24.
10
Strategy for identifying repurposed drugs for the treatment of cerebral cavernous malformation.用于鉴定治疗脑海绵状血管畸形的药物新用途的策略。
Circulation. 2015 Jan 20;131(3):289-99. doi: 10.1161/CIRCULATIONAHA.114.010403. Epub 2014 Dec 8.